ALK-activating homologous mutations in LTK induce cellular transformation.

by J Devon Roll, Gary W Reuther
Published 2012-01-01

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms

by Vasundhara Sharma, Kenneth L. Wright, Pearlie K. Epling-Burnette, Gary W. Reuther
Published 2020-11-01

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

by Andrew T. Kuykendall, Nathan P. Horvat, Garima Pandey, Rami Komrokji, Gary W. Reuther
Published 2020-08-01

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model

by Bhaswati Sarcar, Nicholas T. Gimbrone, Gabriela Wright, Lily L. Remsing Rix, Edna R. Gordian, Uwe Rix, Alberto A. Chiappori, Gary W. Reuther, Pedro G. Santiago‐Cardona, Teresita Muñoz‐Antonia, William Douglas Cress
Published 2019-10-01

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.

by Holly Koblish, Yun-Long Li, Niu Shin, Leslie Hall, Qian Wang, Kathy Wang, Maryanne Covington, Cindy Marando, Kevin Bowman, Jason Boer, Krista Burke, Richard Wynn, Alex Margulis, Gary W Reuther, Que T Lambert, Valerie Dostalik Roman, Ke Zhang, Hao Feng, Chu-Biao Xue, Sharon Diamond, Greg Hollis, Swamy Yeleswaram, Wenqing Yao, Reid Huber, Kris Vaddi, Peggy Scherle
Published 2018-01-01